Development and Validation of a Simple Risk Score to Predict 30-Day Readmission After Percutaneous Coronary Intervention in a Cohort of Medicare Patients

Catheterization and Cardiovascular Interventions - United States
doi 10.1002/ccd.26701
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Development and Validation of a Novel Risk Score for Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction

Cardiovascular Revascularization Medicine
MedicineCardiovascular MedicineCardiology
2019English

Risk Assessment to Predict Arterial and Venous Events in Patients Undergoing Percutaneous Coronary Intervention

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2014English

Risk Assessment of Acute, All-Cause 30-Day Readmission in Patients Aged 65+: A Nationwide, Register-Based Cohort Study

Journal of General Internal Medicine
Internal Medicine
2018English

A Risk Score to Predict the Development of Hepatic Encephalopathy in a Population-Based Cohort of Patients With Cirrhosis

Hepatology
MedicineHepatology
2018English

Development, Validation and Deployment of a Real Time 30 Day Hospital Readmission Risk Assessment Tool in the Maine Healthcare Information Exchange

PLoS ONE
Multidisciplinary
2015English

Interleukin 10: A New Risk Marker for the Development of Restenosis After Percutaneous Coronary Intervention

Genes and Immunity
ImmunologyGenetics
2006English

Angiographic Lesion Complexity Score and In-Hospital Outcomes After Percutaneous Coronary Intervention

PLoS ONE
Multidisciplinary
2015English

P2.13-27 Development, Internal Validation, and Calibration of a Risk Score to Predict Survival in Patients With EGFR Mutant NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Plasma Levels of IL-8 Predict Early Complications in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention

Japanese Heart Journal
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy